- Home
- Results news
- Medistep Healthcare
- Q2 FY27 results
Medistep Healthcare Q2 FY27 results: net profit ₹3.10 crore
Medistep Healthcare Ltd reported consolidated revenue of ₹37.37 crore and a net profit of ₹3.10 crore for Q2 FY27, with EBITDA of ₹4.40 crore and an EBITDA margin of 11.8%. Basic EPS for the quarter was ₹2.18, and there was no exceptional item. The results were approved by the board on 2 November 2026 as unaudited figures.
Key points
- Consolidated revenue for Q2 FY27 was ₹37.37 crore, with total expenses of ₹33.22 crore and no exceptional item.
- EBITDA was ₹4.40 crore, with an EBITDA margin of 11.8%.
- Profit before tax was ₹4.16 crore, and tax expense was ₹1.05 crore.
- Net profit for the quarter was ₹3.10 crore, and basic EPS was ₹2.18.
- Total assets stood at ₹58.41 crore and total equity at ₹40.93 crore as on 30 September 2026.
How did Medistep Healthcare perform in Q2 FY27?
Medistep Healthcare reported consolidated revenue of ₹37.37 crore for Q2 FY27, the July–September 2026 quarter. Total expenses were ₹33.22 crore, and there was no exceptional item. EBITDA for the quarter was ₹4.40 crore, with an EBITDA margin of 11.8%. The company reported figures for the consolidated basis only for the quarter, and no comparison with the year-ago quarter or the previous quarter was given in the available results.
Profit before tax was ₹4.16 crore and tax expense was ₹1.05 crore, leading to a net profit of ₹3.10 crore. Basic EPS for the quarter was ₹2.18. In the standalone presentation, revenue was ₹37.37 crore and profit after tax was ₹3.13 crore, with revenue growth of 6.6% shown against the year-ago period. The board approved the standalone and consolidated unaudited financial results for the half year ended 30 September 2026 on 2 November 2026.
| ₹ crore | Q2 FY27 |
|---|---|
| Revenue from operations | 37.37 |
| Other income | 0 |
| Total expenses | 33.22 |
| EBITDA | 4.40 |
| EBITDA margin | 11.8% |
| Profit before tax | 4.16 |
| Tax | 1.05 |
| Net profit | 3.10 |
| EPS (₹) | 2.18 |
EBITDA here is revenue from operations less operating costs (total expenses excluding finance costs and depreciation): before other income and exceptional items. Growth is shown only when both figures are positive. Source: Company's results filing (XBRL).
What do the balance sheet and cash flow show?
As on 30 September 2026, Medistep Healthcare reported total assets of ₹58.41 crore and total equity of ₹40.93 crore on the consolidated basis. Borrowings stood at ₹5.12 crore and cash was ₹0.7 crore. Inventories were ₹10.52 crore, trade receivables ₹41.42 crore and trade payables ₹7.66 crore. No previous balance sheet date was available in the results for a comparison. On the standalone basis, the filing states that shareholders' funds were ₹4,095.39 lakh as on 30 September 2026 against ₹3,782.46 lakh as on 31 March 2026.
For the half year ended 30 September 2026, consolidated cash flow from operating activities was ₹0.86 crore, while investing cash flow was negative ₹0.48 crore and financing cash flow was negative ₹0.29 crore. Capital expenditure during the period was ₹0.48 crore. No year-earlier cash flow comparison was given in the available results. The standalone statement of assets and liabilities showed short-term borrowings of ₹512.39 lakh as on 30 September 2026, compared with ₹518.13 lakh as on 31 March 2026.
| ₹ crore | As of 30 September 2026 |
|---|---|
| Total assets | 58.41 |
| Total equity | 40.93 |
| Borrowings | 5.12 |
| Cash and equivalents | 0.70 |
| Inventories | 10.52 |
| Trade receivables | 41.42 |
Source: Company's results filing (XBRL).
| ₹ crore | H1 FY27 |
|---|---|
| Cash from operations | 0.86 |
| Cash from investing | −0.48 |
| Cash from financing | −0.29 |
| Capital expenditure | 0.48 |
Source: Company's results filing (XBRL).
Quick answers
What was Medistep Healthcare's revenue in Q2 FY27?
Revenue from operations was ₹37.37 crore (consolidated).
Did Medistep Healthcare make a profit in Q2 FY27?
Yes. Net profit was ₹3.10 crore.
What was Medistep Healthcare's EPS in Q2 FY27?
Basic earnings per share were ₹2.18.
When did Medistep Healthcare announce its Q2 FY27 results?
On 2 November 2026, in a filing to the NSE.
Sources
- Outcome of Board Meeting (NSE, 2 November 2026) · PDF
- Outcome of Board Meeting (NSE, 2 November 2026) · PDF
How this was written: every figure in the tables and charts is calculated from the company’s filed results (XBRL) and MarketPing’s price measurements. The text is drafted with AI from those figures and the filings, and a checker removes any sentence carrying a number it cannot trace to them. How we write these.
This is information, not investment advice. MarketPing does not recommend buying or selling any security.